Matt Brash shut down for the season with right lat inflammation

Matt Brash is done for 2026. The Mariners have shut down the right-handed reliever after a recent MRI revealed more inflammation in his right lat, per Ryan Divish of The Seattle Times. Brash had already been on the injured list with a right lat strain, retroactive to June 9th, and the new imaging — while showing no structural damage — extended his timeline well past any realistic return window. Per Divish, Brash will not throw for eight weeks, putting an end to his season.

What happened

Brash entered 2025 already carrying the weight of a long road back. Tommy John surgery wiped out his entire 2024 campaign and pushed his return back by a month. He came back to the injured list in June with the lat strain, and the club was monitoring his progress when the MRI delivered the latest setback. The inflammation is recurring rather than a new structural problem — a distinction that matters for what comes next — but the eight-week no-throw window makes any 2026 appearance impossible.

Per Divish, Brash should be ready for a normal offseason throwing program, which is the relevant piece of news for anyone thinking past this season. The shutdown closes out his year, but the imaging finding is not, per the report, a career-altering development.

Why it matters

The Mariners lose a reliever who, when healthy, has been one of the more compelling arms in their bullpen. The lat inflammation news arrives at a moment when the club is already managing considerable roster movement: within the past several days, Seattle selected the contract of outfielder Stuart Fairchild to fill the spot vacated by Víctor Robles, who went to the family emergency list, and outrighted Connor Joe to Triple-A Tacoma after he cleared waivers. That is a lot of shuffling for a team trying to hold its footing in September.

The Brash shutdown carries a different kind of weight — not a transaction to manage, but a reminder of how much the club has invested in a pitcher who has now lost significant time in back-to-back seasons to serious arm trouble. The lat inflammation is a separate problem from the Tommy John surgery, which makes the pattern worth noting even if the MRI's no-structural-damage finding is genuinely encouraging.

The numbers

The most useful frame for understanding what Seattle is missing is Brash's 2023 season, the last time he was fully healthy and pitching at the major-league level. He threw over 70 innings that year and posted a 3.06 ERA. The strikeout rate was the headline: he punched out 34.7% of opposing hitters, a figure that puts him in elite company for a reliever. He also kept the ball on the ground, which helped offset a walk rate that ran a few too many free passes.

The one number that complicates the ERA picture is a .380 opponents' batting average on balls in play — an unusually high mark that suggests some bad luck was baked into that 3.06. Ryan Divish of The Seattle Times notes there is an argument that Brash was even better than his ERA indicated, which is a reasonable read when the underlying contact and strikeout profile is that strong.

That 2023 season is now the primary evidence for what Brash can be, because 2024 was lost entirely to Tommy John surgery and 2025 has been interrupted by the lat. The offseason throwing program timeline, per Divish, keeps that argument alive for the future.

Where the club stands

The Mariners are 66-76 (.465), sitting third in the AL West, seven games back of the division lead. In the Wild Card picture, they rank eighth, 6.0 games relative to the cut line, on a two-game losing streak. The math is not friendly.

The upcoming schedule keeps them at T-Mobile Park for the immediate stretch. On Saturday, George Kirby is the probable starter against the Athletics, with Jeffrey Springs going for the visitors. Bryan Woo follows on Sunday against the Athletics, opposed by Gage Jump. The Rangers come to town Tuesday.

September expanded the active roster to 28 players under general league rules, which gives the club some flexibility in how it fills out the bullpen for the final weeks. The Brash spot on the injured list has been occupied since June; the shutdown formalizes what the roster has already been operating around for months.

What we don't know yet

Ryan Divish of The Seattle Times does not specify whether Brash will be transferred to the 60-day injured list, though the timeline makes the practical distinction largely academic at this point. The eight-week no-throw window is the operative fact; the offseason throwing program readiness is an expectation per the report, not a guarantee, and Divish appropriately frames it as such.

What the MRI does not tell us — and what the report does not claim to know — is how Brash's lat responds to rest and whether the recurring inflammation pattern shapes the club's thinking about his role heading into next year. That is a question for the offseason.

What to watch

The immediate question for Mariners fans is how the bullpen holds up through a September that already has the club on a two-game skid and well outside the Wild Card picture. Brash's absence has been a fact of life since June, so the shutdown does not change the operational reality the roster has been living with — but it does close the door on any late-season return that might have been quietly penciled in somewhere.

The more meaningful watch item is the offseason. Per Divish, Brash is reportedly on track for a normal throwing program when that time comes. If that holds, the 2023 strikeout rate and ground-ball profile give the Mariners a reason to be patient. A reliever who posts a 3.06 ERA and strikes out 34.7% of hitters — and who, per the .380 BABIP, may have been pitching even better than that line suggests — is worth waiting on. The desk will not tell you whether it all comes together. But it will be watching.